| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $782.1M | +40.2% |
| Cost of Revenue | $390.6M | +38.7% |
| Gross Profit | $391.6M | +41.8% |
| R&D Expense | $105.5M | +13.8% |
| SG&A Expense | $69.6M | +71.3% |
| Operating Income | $151.0M | +57.6% |
| Pre-tax Income | $166.3M | +43.1% |
| Income Tax | $35.0M | +80.9% |
| Net Income | $103.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $407.4M | +123.8% |
| Short-term Investments | $19.4M | -9.1% |
| Accounts Receivable | $387.0M | +36.7% |
| Inventory | $598.0M | +9.6% |
| Current Assets | $1.48B | +26.1% |
| Total Assets | $1.86B | +24.5% |
| Current Liabilities | $641.2M | +28.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $152.4M | +302.4% |
| Capital Expenditures | $82.5M | +33.3% |
| Investing Cash Flow | -$12.0M | -77.3% |
| Financing Cash Flow | $92.5M | +399.1% |
| Free Cash Flow | $70.0M | +151.0% |
| +34.0% |
| EPS (Basic) | $1.67 | +29.5% |
| EPS (Diluted) | $1.53 | +31.9% |
| Long-term Debt |
| $150.0M |
| +147.0% |
| Total Liabilities | $759.8M | +34.5% |
| Stockholders' Equity | $904.6M | +17.9% |